News: Oxford BioMedica PLC (OXB.L)

OXB.L on London Stock Exchange

4.00GBp
12:15pm EDT
Price Change (% chg)

0.00p (+0.00%)
Prev Close
4.00p
Open
4.00p
Day's High
4.00p
Day's Low
4.00p
Volume
291,902
Avg. Vol
1,789,114
52-wk High
4.72p
52-wk Low
1.77p

Search Stocks
Select another date:

Mon, Oct 13 2014

BRIEF-Oxford Biomedica buys Windrush Court Office for 3.2 mln stg

* Oxford Biomedica has acquired freehold of Windrush Court Office and laboratory facilities in transport way, Oxford, England, for a total cash consideration of £3.2 million Source text for Eikon: Further company coverage:

BUZZ-Oxford Biomedica: Signs 3-year deal with Novartis

** Oxford Biomedica's shares rise more than 20 pct after the gene-and-cell-based therapeutics maker says it has signed a three-year contract with Novartis AG that could bring in up to $90 million for the British company.

BRIEF-Oxford Biomedica signs further contract with Novartis for LentiVector

* Oxford Biomedica announces new process development and manufacturing collaboration which includes lentivector  licence agreement

BRIEF-Oxford Biomedica H1 rev 4.7 mln pounds

* H1 net loss of £4.8 million (H1 2013 £5.9 million) Source text for Eikon: Further company coverage:

BRIEF-Oxford Biomedica appoints Paul Blake chief development officer

* Paul Blake to take executive role as chief development officer Source text for Eikon: Further company coverage:

Select another date:
Search Stocks